Detailed answers about PREMIER BRITISH ALLERGY CLINIC LIMITED, including incorporation, status, business activity, and accounts information.
When was PREMIER BRITISH ALLERGY CLINIC LIMITED founded?
PREMIER BRITISH ALLERGY CLINIC LIMITED was officially incorporated on 22 December 2020 and is registered under company number 13096402. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PREMIER BRITISH ALLERGY CLINIC LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of PREMIER BRITISH ALLERGY CLINIC LIMITED?
PREMIER BRITISH ALLERGY CLINIC LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PREMIER BRITISH ALLERGY CLINIC LIMITED do?
PREMIER BRITISH ALLERGY CLINIC LIMITED operates in the following sectors: 85422 - Post-graduate level higher education, 86210 - General medical practice activities, 86220 - Specialists medical practice activities. These SIC codes provide insight into the company's business activities and industry focus.
What is PREMIER BRITISH ALLERGY CLINIC LIMITED's registered address?
The registered office address of PREMIER BRITISH ALLERGY CLINIC LIMITED is OFFICE 208, 69, STEWARD STREET, BIRMINGHAM, ENGLAND, B18 7AF. This is the official address filed with Companies House for legal and statutory correspondence.
Is PREMIER BRITISH ALLERGY CLINIC LIMITED financially stable?
The most recent accounts for PREMIER BRITISH ALLERGY CLINIC LIMITED were made up to 30 June 2024, filed as MICRO ENTITY. Next accounts are due by 31 March 2026.